Microbial consortia and uses thereof
OwnerArjun S. Raman, Ana Rita Almeida de Oliveira +1inventors
InventorsArjun S. Raman, Ana Rita Almeida de Oliveira, Seppe Kuehn
Life of this patent
Estimating the term…
Abstract
The present document relates to microbial consortia and uses thereof.
Claims23
A composition comprising a bacterial population comprising at least one bacterial strain, wherein the bacterial strain(s) is/are a Clostridium innocuum strain, a Clostridium symbiosum strain, a Collinsella aerofaciens strain, an Escherichia coli strain, a Bacteroides xylanisolvens strain, a Lacrimispora celerecrescens strain (or Clostridium celerecrescens strain), a Bacteroides caccae strain, a Blautia faecis strain, a Blautia obeum strain, a Clostridium scindens strain, a Bifidobacterium strain, a Megasphaera massiliensis strain, a Coprococcus comes strain, a Mitsuokella jalaludinii strain, a Blautia producta strain, or any combination thereof.
6-12. (canceled)
14-20. (canceled)
A method for treating or prophylactically treating an infection in a patient, the method comprising administering a therapeutically effective amount of a composition to the patient, thereby treating or prophylactically treating infection, wherein the composition comprises a bacterial population comprising at least one bacterial strain, wherein the bacterial strain is a Clostridium innocuum strain, a Clostridium symbiosum strain, a Collinsella aerofaciens strain, an Escherichia coli strain, a Bacteroides xylanisolvens strain, a Lacrimispora celerecrescens strain, a Bacteroides caccae strain, a Blautia faecis strain, a Blautia obeum strain, a Clostridium scindens strain, a Bifidobacterium strain, a Megasphaera massiliensis strain, a Coprococcus comes strain, a Mitsuokella jalaludinii strain, a Blautia producta strain, or any combination thereof.
(canceled)
A method for modulating one or more short chain fatty acids and/or one or more amino acids in a patient, the method comprising administering an effective amount of a composition to the patient, wherein the composition comprises a bacterial population comprising at least one bacterial strain, wherein the bacterial strain is a Clostridium innocuum strain, a Clostridium symbiosum strain, a Collinsella aerofaciens strain, an Escherichia coli strain, a Bacteroides xylanisolvens strain, a Lacrimispora celerecrescens strain, a Bacteroides caccae strain, a Blautia faecis strain, a Blautia obeum strain, a Clostridium scindens strain, a Bifidobacterium strain, a Megasphaera massiliensis strain, a Coprococcus comes strain, a Mitsuokella jalaludinii strain, a Blautia producta strain, or any combination thereof.
(canceled)
Dependencies are inferred from the claim text.